Magnesium adjunctive therapy in atrial arrhythmias

Area of Science:

• Cardiology
• Electrophysiology
• Biochemistry

Background:

• Magnesium (Mg) is a critical intracellular ion influencing cardiac metabolism and electrophysiology.
• Intracellular Mg deficiency is prevalent in patients experiencing arrhythmias, often not reflected in serum Mg levels.
• This intracellular deficit provides a rationale for magnesium's antiarrhythmic properties.

Purpose of the Study:

• To explore the role of magnesium in atrial antiarrhythmic therapy.
• To evaluate magnesium's potential to improve the benefit-to-harm ratio of antiarrhythmic treatments.
• To assess magnesium's efficacy and safety as a monotherapy in cardiothoracic surgery patients.

Main Methods:

• Analysis of intracellular vs. serum magnesium concentrations in arrhythmia patients.
• Review of existing literature on magnesium's electrophysiologic effects.
• Clinical evaluation of magnesium's impact on antiarrhythmic efficacy and proarrhythmic risk.

Main Results:

• Intracellular magnesium deficiency is a significant factor in patients with arrhythmias.
• Magnesium enhances atrial antiarrhythmic efficacy.
• Magnesium reduces the proarrhythmic potential associated with antiarrhythmic drugs.
• Magnesium demonstrates direct antiarrhythmic efficacy as monotherapy.

Conclusions:

• Magnesium plays a vital role in cardiac electrophysiology and metabolism.
• Addressing intracellular magnesium deficiency is crucial for managing arrhythmias.
• Magnesium offers a favorable risk-benefit profile, enhancing antiarrhythmic therapy and providing direct efficacy.